EORTC QLQ-C30 and EORTC QLQ-PR25 — tools for assessing the quality of life of men suffering from prostate cancer

Introduction and objective. The assessment of the quality life in cancer patients has become an indispensable element clinical trials applications new treatments surgical variants springs from a desire to achieve therapeutic success various aspects patients’ lives. This article aims present describe EORTC QLQ-C30 questionnaire, used for assessing life, complementary QLQ-PR25 which is cases prostate cancer. Brief description current state knowledge. Cancer diagnoses lead psychological, physical, emotional, economic burdens can have great effect on life. population increasing year year, creating many challenges healthcare systems. In Poland, accounts 19.6% all diagnosed cancers male population, thus presenting growing trend. multiplicity possible treatment methods interest quality-of-life means that proper choice depends part results evaluate among being treated by specific methods. For such assessment, European Organization Research Treatment developed questionnaire impact disease different lives, as well supplementary questionnaires particular types Conclusion. application standardized becoming integral trials, which, along with other factors, may help selection most appropriate